⌘K
Loading ticker…
Vanda Pharmaceuticals Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Vanda Pharmaceuticals Inc. (VNDA) has a 3-month relative strength percentile of 21 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.2%, relative volume 1.66×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
21 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
VNDA is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $12M notional. Top 3 carry $33M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $12M |
| XBIState Street SPDR S&P Biotech ETF | 0.16% | $12M |
| IWMiShares Russell 2000 ETF | 0.01% | $9M |
| VXFVanguard Extended Market ETF | 0.01% | $5M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $796K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VNDA Jan avg: -8.30% median: -11.22% win: 25% σ: 8.74% n: 4 2022-04-12 → 2026-05-29 | VNDA Feb avg: 8.53% median: 13.05% win: 75% σ: 17.76% n: 4 2022-04-12 → 2026-05-29 | VNDA Mar avg: -7.16% median: -5.81% win: 25% σ: 11.63% n: 4 2022-04-12 → 2026-05-29 | VNDA Apr avg: -1.02% median: -1.74% win: 40% σ: 11.18% n: 5 2022-04-12 → 2026-05-29 | VNDA May avg: -1.92% median: -3.09% win: 20% σ: 6.00% n: 5 2022-04-12 → 2026-05-29 | VNDA Jun avg: 10.24% median: 10.66% win: 100% σ: 1.00% n: 4 2022-04-12 → 2026-05-29 (current) | VNDA Jul avg: -4.94% median: -5.42% win: 25% σ: 7.32% n: 4 2022-04-12 → 2026-05-29 | VNDA Aug avg: -2.61% median: -5.64% win: 25% σ: 9.84% n: 4 2022-04-12 → 2026-05-29 | VNDA Sep avg: -7.31% median: -8.98% win: 25% σ: 9.49% n: 4 2022-04-12 → 2026-05-29 | VNDA Oct avg: -1.58% median: 0.27% win: 50% σ: 8.02% n: 4 2022-04-12 → 2026-05-29 | VNDA Nov avg: 5.78% median: 7.48% win: 75% σ: 15.98% n: 4 2022-04-12 → 2026-05-29 | VNDA Dec avg: 9.69% median: 3.23% win: 50% σ: 41.08% n: 4 2022-04-12 → 2026-05-29 |